Related Experiment Video
Updated: Aug 12, 2025
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Aspergillus infection in chronic obstructive pulmonary diseases
Liang Guo1, Xiulin Wu2, Xueling Wu3
1Institute of Respiratory Disease, The Second Affiliated Hospital (Xinqiao Hospital), Army Medical University, Chongqing, China.
Abstract:
Chronic obstructive pulmonary disease (COPD) is a chronic airway non-specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection in patients with AECOPD, especially aspergillus infection, has gradually increased. The forms of aspergillus infection present in COPD patients include sensitisation, chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA). This review will summarise diagnostic and treatment of aspergillus in COPD patients.
Insights
Pulmonary fungal infections, particularly Aspergillus, are increasingly common in COPD patients due to medication use. This review covers diagnosis and treatment of Aspergillus in COPD.
Area of Science:
- Pulmonology
- Infectious Diseases
- Medical Mycology
Background:
- Chronic obstructive pulmonary disease (COPD) is a progressive lung disease.
- Increased use of antibiotics, glucocorticoids, and immunosuppressants in COPD patients has led to a rise in pulmonary fungal infections.
- Aspergillus species are a significant cause of fungal infections in COPD patients, presenting as sensitization, chronic pulmonary aspergillosis (CPA), or invasive pulmonary aspergillosis (IPA).
Purpose of the Study:
- To review the diagnostic approaches for Aspergillus infections in COPD patients.
- To summarize current treatment strategies for Aspergillus infections in COPD patients.
- To provide an overview of the clinical significance of Aspergillus in the context of COPD exacerbations.
Main Methods:
- Literature review of diagnostic methods for pulmonary Aspergillus.
- Synthesis of treatment guidelines and clinical evidence for managing Aspergillus in COPD.
- Analysis of the epidemiology and clinical presentations of Aspergillus infections in COPD.
Main Results:
- Aspergillus sensitization, CPA, and IPA are recognized forms of infection in COPD.
- Diagnosis relies on a combination of clinical, radiological, and microbiological findings.
- Treatment varies based on the type and severity of infection, with antifungal agents being the mainstay.
Conclusions:
- Aspergillus infections pose a growing threat to COPD patients.
- Early and accurate diagnosis is crucial for effective management.
- Tailored treatment strategies are essential to improve outcomes for COPD patients with Aspergillus infections.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction